Dexamethasone or prednisolone for asthma exacerbations in children: A cost-effectiveness analysis.

Carlos E Rodriguez-MartinezMonica P Sossa-BriceñoJose A Castro-Rodriguez

Published in: Pediatric pulmonology (2020)

The present study shows that in Colombia, a middle-income country, compared with oral dexamethasone, the use of prednisolone for treating acute pediatric asthma is cost-effective, yielding a similar probability of hospitalization at lesser overall costs.

Keyphrases

chronic obstructive pulmonary disease
lung function
high dose
low dose
liver failure
allergic rhinitis
young adults
physical activity
mental health
respiratory failure
drug induced
air pollution
hepatitis b virus
intensive care unit